Parametrica Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Parametrica Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,663	Closed	-$334K	–	160
2019 Q1	$334K	Buy	+3,663	New	+$300K	0.71%	36
2018 Q3	–	Sell	-3,889	Closed	-$386K	–	205
2018 Q2	$386K	Buy	+3,889	New	+$336K	1.83%	17
2017 Q2	–	Sell	-5,974	Closed	-$598K	–	432
2017 Q1	$598K	Buy	+5,974	New	+$638K	0.62%	21

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GAM

Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Parametrica Management's CBPO Position: Q2 2019 in Review

Parametrica Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2019, closing a stake of 3,663 shares — an estimated $334K sold.

Parametrica Management first reported a position in CBPO in Q1 2017 and held it in 3 quarters. The position peaked at $598K in Q1 2017. 71 funds tracked by Wall St. Rank hold CBPO as of Q2 2019.

Parametrica Management reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2019 after selling out during the quarter.
Parametrica Management sold 3,663 China Biologic Products Holdings, Inc. shares in Q2 2019, an estimated $334K.
Parametrica Management first reported a position in China Biologic Products Holdings, Inc. in Q1 2017 and held it in 3 quarters.
Parametrica Management's China Biologic Products Holdings, Inc. position peaked at $598K in Q1 2017.
71 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2019.

Based on Parametrica Management's 13F filing for Q2 2019, filed 13 Aug 2019.